Fraser MacDonald
Direttore/Membro del Consiglio presso PHARMALA BIOTECH HOLDINGS INC.
Patrimonio netto: 15 800 $ in data 30/04/2024
Profilo
Fraser MacDonald is currently an Independent Director at Pharmala Biotech Holdings, Inc. and a Director at Pharmala Biotech, Inc. He completed his undergraduate degree at Queen's University and his graduate degree at Bond University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 27/02/2024 | 100 000 ( 0.12% ) | 15 800 $ | 30/04/2024 |
Posizioni attive di Fraser MacDonald
| Società | Posizione | Inizio |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Direttore/Membro del Consiglio | 21/03/2021 |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Formazione di Fraser MacDonald
| Queen's University | Undergraduate Degree |
| Bond University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Fraser MacDonald